S 4692·Federal·senate
Homeopathic Drug Product Safety, Quality, and Transparency Act
In CommitteeFiled Jun 4, 2026
Sponsor: Sen. Tuberville, Tommy [R-AL] (R)
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 4, 2026
Summary
The bill adds a new section to the Federal Food, Drug, and Cosmetic Act that treats homeopathic medicines as a separate category. It tells the FDA how to define these products, what safety and labeling rules they must follow, and creates a committee to advise on the regulations. The goal is to give manufacturers clear rules while protecting consumers.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when S 4692 changes status, plus AI-powered summaries and stage predictions.
Sign up free